MedPath

东营天东制药有限公司

Ownership
-
Established
1992-12-22
Employees
-
Market Cap
-
Website
http://www.td-pharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Enoxaparin Sodium

Product Name
依诺肝素钠
Approval Number
国药准字H20143051
Approval Date
Jul 6, 2023
NMPA

Enoxaparin Sodium Injection

Product Name
依诺肝素钠注射液
Approval Number
国药准字H20173386
Approval Date
Sep 29, 2022
NMPA

Enoxaparin Sodium Injection

Product Name
依诺肝素钠注射液
Approval Number
国药准字H20173385
Approval Date
Sep 29, 2022
NMPA

Heparin Sodium

Product Name
肝素钠
Approval Number
国药准字H20058187
Approval Date
Feb 16, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.